{
  "ticker": "JNJ",
  "target_date": "2025-06-16",
  "actual_date": "2025-06-16",
  "collected_at": "2025-12-08T11:53:46.041581",
  "price": {
    "open": 154.3,
    "high": 154.38,
    "low": 152.36,
    "close": 153.11680603027344,
    "volume": 7024000,
    "change_1d_pct": -1.2,
    "change_7d_pct": 1.02,
    "change_30d_pct": 0.28
  },
  "technicals": {
    "rsi_14": 56.98,
    "sma_20": 151.94,
    "sma_50": 150.93,
    "macd": 0.823,
    "macd_signal": 0.494,
    "macd_histogram": 0.329,
    "bb_upper": 155.55,
    "bb_lower": 148.32,
    "price_vs_sma20_pct": 0.78,
    "price_vs_sma50_pct": 1.45,
    "volume_ratio": 0.93
  },
  "fundamentals": {
    "market_cap": 489110994944,
    "pe_ratio": 19.59556,
    "forward_pe": 19.151886,
    "price_to_book": 6.1617146,
    "price_to_sales": 5.3078275,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.31,
    "pct_from_52w_low": 44.31
  },
  "macro": {
    "spy": {
      "price": 599.24,
      "change_1d_pct": 0.95,
      "change_7d_pct": 0.59
    },
    "vix": {
      "level": 19.11,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.45
    },
    "dollar_index": {
      "level": 98.0
    },
    "gold": {
      "price": 3396.4
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know",
      "source": "Yahoo",
      "datetime": 1750110302,
      "summary": "In the most recent trading session, Johnson & Johnson (JNJ) closed at $155.22, indicating a -1.2% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=b7c7459e7488eb085034f9d17d490d4ceff55e080edd6791ad6ad911af7c327a"
    },
    {
      "headline": "Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q1 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1750108183,
      "summary": "AQR Capital's Q1'25 portfolio hits $97.07B, with top picks in AAPL, NVDA, & AMZN. Active portfolio adjustments show a quantitative, diversified approach. See more.",
      "url": "https://finnhub.io/api/news?id=51b45bd42e92498ec52abd010edf461044394127b04a8428f9c402a3b43b4ef8"
    },
    {
      "headline": "Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?",
      "source": "Yahoo",
      "datetime": 1750078800,
      "summary": "JNJ's Innovative Medicines unit shows a growth trend, defying Stelara LOE and the negative impact of the Part D redesign.",
      "url": "https://finnhub.io/api/news?id=5f33d906adc1b592893ec7877c438cb630f84195085347af1aa3d983c53d2697"
    },
    {
      "headline": "J&J reports results from antibody combo trial for MM patients",
      "source": "Yahoo",
      "datetime": 1750074181,
      "summary": "The investigational combo resulted in an ORR of 78.9%, with over half of the subjects achieving a complete response or better.",
      "url": "https://finnhub.io/api/news?id=e857eac44426e3deff3c9c58c92212550c83ed8861c68c5e26ae6e3a8931bf62"
    },
    {
      "headline": "Johnson & Johnsons Dual Targeting Car T Cell Therapy Shows Encouraging First Results In Large B Cell Lymphoma",
      "source": "Finnhub",
      "datetime": 1750065449,
      "summary": "the most common type of aggressive lymphoma, a blood cancer that originates in the lymphatic system.1,2 These data were presented as an oral presentation at the 2025 European Hematology Association ...",
      "url": "https://finnhub.io/api/news?id=c087a0d712d780b2a880f3b6cd10b6c9ca9fb7e59f68afa1016252b742b658f2"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760229.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000154/xslF345X05/wk-form4_1749760229.xml"
    },
    {
      "form": "8-K",
      "date": "2025-06-10",
      "description": "jnj-20250610.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000152/jnj-20250610.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}